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This paper answers five questions about the societal impact of research. Firstly, we examine the
opinions of research group leaders about the increased emphasis on societal impact, i.e. does it
influence their research agenda, communication with stakeholders, and knowledge dissemination
to stakeholders? Furthermore, we investigate the quality of their societal output. We also study
whether the societal and scholarly productivity of academic groups are positively or negatively
related. In addition, we investigate which managerial and organisational factors (e.g. experience of
the principal investigator, group size and funding) influence societal output. Finally, we show for
one case (virology) that societal impact is also visible through indirect links. Our study shows that
research group leaders have a slightly positive attitude towards the increased emphasis on the
societal impact of research. The study also indicates a wide variety of societal-oriented output.
Furthermore, the societal and scientific productivity of academic groups are unrelated, suggesting
that stimulating social relevance requires specific organisational and contextual interventions.
Keywords: societal output; research groups; research funding; science communication; incentive
structures; science system.
1. Introduction
Academic science is currently shaped by pressure towards
academic excellence and by aspirations towards knowledge
transfer and research activities beyond academia. Over the
years, discussions about the societal value of academic
science have become more extensive—and research
funding agencies increasingly ask about the explicit
societal relevance of proposed research. Within science
policy studies, a series of concepts has been introduced
to theorise these changes in the science-society relation-
ship: ‘mode 2 knowledge production’ (Gibbons et al.
1994), ‘triple helix of university–government–industry re-
lations’ (Etzkowitz and Leydesdorff 1995), ‘knowledge
society’ (Stehr 1994), ‘Pasteur’s quadrant’ (Stokes 1997),
‘third mission activities’ (Pålsson et al. 2009; Göransson
et al. 2009; Krücken et al. 2009; Gregersen et al. 2009;
Ca 2009) and ‘academic entrepreneurial cultures’
(Göktepe-Húlten 2008). Potentially, society can benefit
from academic research in various ways, ranging from
contributions to culture and education to specific insights
or products with economic or socio-political value. Despite
the stronger emphasis on societal impact in science policy
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and the numerous theoretical contributions, empirical
studies on the generation of societal impact are scarce.
In this paper, our aim is to contribute empirical evidence
on how the quest for societal relevance is taken up by
principal investigators.1 We investigate five research ques-
tions: (1) What are the opinions of research leaders about
the increasing emphasis on the societal impact of research?
(2) Which different types of direct societal output products
do they produce? After having answered these questions,
we focus on the indirect way of realising societal impact:
(3) How is societal orientation reflected in scholarly
output? We answer this third research question for
virology, one of the core fundamental research fields in
the domain under study. Next, we address two highly
debated issues that might explain research leaders’
opinions about societal relevance and their societal per-
formance. First, it is often argued that academic excellence
automatically produces societal relevance: the latter does
not need to be encouraged. Others argue that a focus on
societal relevance endangers academic research. Such a
focus may hinder fundamental research due to a premature
search for applications. Therefore, the next question is:
(4) How are societal and scholarly productivity related?
Secondly, policy makers are looking for ways to encourage
socially relevant research. This leads to the last question:
(5) How does management and organisation of research,
such as funding arrangements and the characteristics of
research groups, influence societal performance?
In this paper, we focus on the biomedical and health dis-
ciplines. The primary reason for this is their obvious societal
role in improving health and wellbeing. Progress made in
biomedical and health research over the years has resulted
in an increased quality of life and a reduced mortality and
morbidity (Garcia-Romero 2006). Biomedical and health
research has a dual mission; it is concerned with both the
production of scientific knowledge and with the utility and
implementation of scientific achievements in the health care
system (Council for Medical Sciences 2002). The dual
mission refers to the concept of translational research.
Translational research aims not only to obtain fundamen-
tal knowledge, but also to translate this knowledge into
applicable treatments: research that seeks to move from
bench to bedside; from laboratory experiments to actual
point-of-care patient applications (Woolf, 2008).2
Therefore, research evaluations should not only focus on
the scientific performance of biomedical and health
research, but also take its societal quality into account.
Secondly, biomedical and health disciplines make up
about 40% of all research in the Netherlands, as in
many other developed countries, and it covers a wide
variety of research types. We distinguish between three
research types based on their relationship with patients:
(1) para-clinical groups with an advisory relationship
with patients and mostly a ‘social sciences’ research per-
spective (e.g. social medicine, public health and medical
psychology); (2) pre-clinical groups with little or no
patient contact and laboratory-based fundamental
research (e.g. immunology, micro-biology and neurosci-
ences); and (3) clinical groups with direct patient contact
and an application-oriented type of research (e.g. derma-
tology, nephrology and psychiatry). Therefore, the results
can be generalised to a broad range of research fields.
Thirdly, biomedical and health research is heavily de-
pendent on external research funding (Ellenbroek et al.
2002; Van der Weijden 2007). Scientists, research groups
and organisations are accountable for their use of funds
to a range of public, not-for-profit (charities) and commer-
cial sources. Consequently an evaluation of how and why
biomedical and health research delivers social benefits is
crucial to the stakeholders, who include government, a
variety of funders, industry, regulatory bodies, patients
and the general public (UK Evaluation Forum 2006). In
other words, societal relevance (Hessels et al. 2009) is cur-
rently at the core of the relationship between academic bio-
medical and health science and society. This underlines the
importance of further improving the close relationship
between academic research and clinical practice, and the
dialogue with stakeholders.3 Hemlin and Rasmussen
(2006) argue that discussions about the societal value of
academic science have consequences for research evalu-
ations, which should now be viewed as an open monitoring
system in which scientific, industrial and public actors
connect in a dynamic dialogue. However, project selection
and research evaluation procedures do not usually cover the
societal value of academic research in an explicit manner,
and explicit criteria developed for this purpose are still in
their infancy. Indicators to measure societal relevance are
not available (Atkinson-Grosjen and Douglas 2010; De
Jong et al. 2011). Within the Dutch context, ZonMw,4 the
Dutch research council for biomedical and health research,
is one of the first councils that takes societal relevance ex-
plicitly into account in its selection procedures.
1.1 Methods for evaluating societal impact
In the meantime, several attempts have been made to
develop methods for evaluating the societal relevance of
research. One example is the project Evaluating Research
in Context (ERiC) (and the related EU-funded SIAMPI
project)5 which recently carried out pilot studies within
Dutch universities, in various disciplines, such as architec-
ture, electrical engineering, mechanical engineering,
nanoscience, computer science and law (see De Jong
et al. 2011, for a brief overview). Another example is the
study by Meagher et al. (2008) who developed a method to
assess the impact of social science research conducted in
the UK on policy and practice. Also worth mentioning
here is the study by Laredo and Mustar (2000), which
proposed a method to characterise the activity profile of
research laboratories as a research compass card. They
argue that besides contributing to the production of scien-
tific knowledge and to education and training, laboratories
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are also involved in the creation of competitive advantages
and of public and collective goods, and participate in the
public debate. Indicators to measure these activities are
presented. Unfortunately, examples of indicators that
measure the participation of laboratories in the public
debate were not explicitly described. Finally, Merkx and
Van den Besselaar (2008) proposed an approach to
evaluate the societal relevance at the research field level,
and applied this to coastal research.
Within biomedical and health research, specific methods
have been proposed and applied—the biomedical and
health fields seem to be leading in this respect (Lyall
et al. 2004). The three best known research evaluation
frameworks (for an overview see Brutscher et al. 2008)
used in health research are: first, the Payback
Framework, developed in the UK by Buxton and col-
leagues (Buxton and Hanney 1996; Hanney et al. 2003;
2004). It describes the wide range of health-related
research and the social and economic benefits that may
result from biomedical research projects and programs.
The Canadian Academy of Health Sciences (2009)
designed the CAHS impact framework which builds on
the Payback Framework. It can be used to describe
impact at various levels (individual, provincial, national
and international), and to define funders returns by quan-
tifying the value of impact on end-users in dollars invested.
Secondly, the Research Institute Framework was de-
veloped by the Royal Netherlands Academy of Arts and
Sciences (KNAW) (Council for Medical Sciences 2002) in
the Netherlands. It measures the societal impact of health
care research on the level of research institutes. Thirdly,
there is the Societal Impact Framework (van Ark and
Klasen 2007), which focuses on communication between
researchers and a variety of stakeholders. Within this
framework, the societal outcomes of research are evaluated
in terms of the quality of the various communication
processes. Some work has been done on the application
of the frameworks in order to improve our understanding
of societal impact, i.e. how research is translated from
bench to bedside (e.g. Nason et al. 2007; Oortwijn 2007;
Advisory Council on Health Research 2007). Elements of
these frameworks were used in the construction of our
questionnaire.
1.2 Societal relevant output and societal impact
The impact of research is generated through the commu-
nication networks. That holds for scholarly impact on
peers in the field, for scholarly impact in other fields and
for societal impact. Researchers produce output for peers
and for other (societal) audiences. The quality and impact
of the output is decided by the specific audiences that it is
intended for. Impact can be measured in terms of the
reaction of an audience on the output. For example, sci-
entific impact becomes visible through actions such as cit-
ations and downloads, or through sales of papers or
books. Societal impact may become visible through invita-
tions for participating in advisory committees, or through
the adoption of medical guidelines. Within this perspec-
tive, we distinguish between direct and indirect societal
impact (De Jong et al. 2011).
First, societal impact can be produced directly by
producing non-scholarly output for stakeholders, based
on the expertise of the researchers who are involved.
Non-scholarly means that the output is not meant for
peers in the field, but for the other audiences such as the
general public, policy makers and medical professionals.
These interactions are represented by arrows (C and D)
in Fig. 1.
With regard to directly generated societal impact, there
is a variety of ‘non-scholarly’ output of research that may
contribute to the improvement of health and wellbeing,
such as advice on new treatments, policy advice and
plans for organising healthcare systems, strategies for
health care innovation, or informing the general public
about health risks. These outputs can—just as scholarly
output—be measured at the group level.
Secondly, societal impact can be produced indirectly
where research output (new knowledge) is taken up by




















Figure 1. Interaction between research and societal audiences.
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own research that leads to results relevant for stakeholders
(C arrows), such as medical professionals working in
hospitals.
Indirectly generated societal impact refers to biomedical
and health research results in academic papers, with new
knowledge that may—when taken up in patient care, drugs
or instruments—contribute to the improvement of health
and to new treatments for diseases. Sometimes the contri-
butions may be the effect of serendipity, but biomedical
and health research is often explicitly directed at scholarly
problems that have to be solved in order to make progress
in curing or preventing diseases. For example, fundamen-
tal results in molecular cell biology may inform basic
research in virology and immunology. The results of the
two latter fields may in turn inform AIDS research which
produces useful therapies to be used in patient care. In
other words, fundamental research results are taken up
in a sequence of steps by other, more applied researchers,
and finally by professionals. In biomedical research, a
concept has been introduced for this: translational
research.
In this paper, we focus on the direct link between re-
searchers and societal audiences. However, we will show
for one case (virology) that societal orientation is visible
through indirect links.6
2. Data and methods
2.1 A survey among research leaders
The data were collected in 2007 in a survey among bio-
medical and health research leaders (principal investiga-
tors) employed by university medical centres (UMCs) or
by biomedical public research institutes in the Netherlands
(Van der Weijden 2007; Van der Weijden et al. 2008; 2009).
Names and addresses were obtained from administrative
records. A mail strategy was chosen to collect the data
because principal investigators are difficult to reach by
phone or in person and have, due to their heavy
workload (including patient care duties), limited access
to the web. In total, 188 group leaders returned a
completed questionnaire by post, resulting in an overall
response rate of 27%, which seems acceptable regarding
the target population and chosen strategy (the norm is
36% ±13 (Baruch 1999)). To maximise the response
rate, we used the tailored design method (Dillman 2000).
We obtained information about the research leaders’
opinions on societal impact of research. We used five-point
Likert scales, with answers ranging from totally agree to
totally disagree. The research leaders were also asked to
indicate which types of societal output were realised
(Table 1), including an estimation of the quantity of
societal output in the period 2004–6. Elements of three
societal impact frameworks discussed in Section 1.1 were
used to construct these questions.
The scholarly performance7 was measured by the
number of publications in journals indexed in the Web
of Science of which the principal investigator was a
(co-)author. Impact is measured as citations per full-time
researcher (FTE). Finally, the survey contained questions
about: (1) organisational characteristics (i.e. funding
sources); (2) managerial characteristics (i.e. leadership ex-
perience); and (3) disciplines of the groups’ research within
biomedical and health research (among others, health care
research, immunology and dermatology) (Van der Weijden
2007; Van der Weijden et al. 2008, for more detail about
the survey design).
2.2 Non-response analysis
Non-response analysis shows that the respondents can be
regarded as a representative sample of the Dutch biomed-
ical and health research groups. First, we checked whether
the respondents were evenly distributed among the various
research institutions and the sub-disciplines, and this
proved to be the case. Secondly, we compared scholarly
performance of respondents and non-respondents. Since
publication counts are highly skewed, a Mann–Whitney
test was used. Respondents did not significantly differ
(Mdn=25.0) from non-respondents (Mdn=23.0),
U=62,315.0, p=0.365, r=0.03. The mean difference
between the two groups was also small (33 publications for
respondents versus 31 for non-respondents).
2.3 Some characteristics of the sample
The biomedical and health leaders in the sample supervised
research groups with an average size of 17 FTE staff
members. The average age of the respondents was 53
years in 2007, and the majority were male (87%). Most
of the leaders had been functioning as heads of their
research groups for a long time: on average 12 years. In
74% of the cases, the respondents indicated that they had a
co-leader. Research leaders spent their time on research,
Table 1. Ten types of societal output
1 Presentations to non-scientific public (professionals, policy makers or
patients)
2 Contributions to public media (TV, radio or newspaper)
3 Education for professionals and policy makers, such as retraining
courses
4 Contributions to symposia and conferences directed to societal
communities
5 Membership of committees that are developing guidelines or policy
recommendations
6 Publications in professional or policy journals
7 Clinical guidelines
8 Policy reports
9 Editorships of professional medical and health journals
10 Membership of committees of funding organisations, such as
charities
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management, supervision, education and patient care.
Most groups (87%) were located in a UMC and the
others (13%) were working in public research institutes.
Of the 188 respondents, 34 were leaders of para-clinical
research groups, 73 were research leaders of pre-clinical
research groups and 81 were research leaders of clinical
research groups. Writing and publishing scientific articles
(90%), developing new knowledge (55%) and training
young researchers (36%) were reported to be the most
important goals of the research groups.
2.4 Analysing indirect societal impact of biomedical
research
In order to map the application orientation of basic bio-
medical research, we selected a core, basic research field:
virology. By analysing the journal citation network of the
main journal in this field (Journal of Virology), we
identified the relevant virology journals, as well as
research fields that are a knowledge source for virology
and fields that are using knowledge taken from virology.
This informs us about the relationships between virology
and its applications in clinical and health care oriented
research, in other words, about the relationship between
societal impact and fundamental research. In the second
step, we analysed the titles and keywords of all papers in
virology journals in order to identify words that refer to
the application context of virology knowledge in medical
treatments. The more frequently these title words and
keywords appear, the stronger the application orientation
of fundamental research. We repeated the analysis for a
variety of years, in order to identify changes in application
orientation and in the practical contributions of virology
research. The details of the methods are explained else-
where (Van den Besselaar 2000; Van den Besselaar and
Heimeriks 2006).
3. Findings
3.1 Societal orientation of research leaders
Science policy makers and research managers increasingly
emphasise that research should be useful for society. This
is not received enthusiastically everywhere. For example, a
UK study suggests that researchers who engage in popu-
larisation are seen as ‘lesser’ researchers by their peers, and
that many think that societal output is produced by re-
searchers ‘who are not good enough for an academic
career’ (Royal Society 2006). What is the opinion of bio-
medical and health research leaders about this? Are they
working in an ivory tower, or do they also consider societal
relevance to be of great importance? In the survey, we
asked whether the increasing emphasis on societal impact
has implications for research group goals. Do research
group leaders take societal relevance into account when
formulating the group’s research agenda? And in their
research, are they focusing on existing medical problems










Research in my group takes societal
needs into account
Research in my group is adapted to
medical problems within society





Figure 2. Opinions of research leaders on societal research goals.
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the attitude of research leaders towards societal research
goals is, on average, slightly positive. Compared to
para-clinical and clinical leaders, pre-clinical research
leaders had more neutral views.8
Does this positive attitude towards societal orientation in
research translate into interactions with stakeholders?
When asked about the effects of the recent increase in
emphasis on societal impact, research leaders reported a
slight increase of interactions with various stakeholders
(Fig. 3 and Table A2). Overall, respondents had neutral
views about changes in their interactions with professionals
in prevention and care, policy makers, the general public,
patient organisations and (pharmaceutical) industry and
firms. In general, pre-clinical group leaders had more
neutral attitudes towards the improved interactions with
stakeholders compared to para-clinical and clinical
leaders, similar to their opinion on societal research goals.
Interactions with industry show a slightly different pattern:
group leaders from all three disciplines do not report
intensified interaction9 with companies (see Fig. 3).
The next question is whether the increasing emphasis on
the societal impact of biomedical and health research
results in knowledge dissemination. Does it result in
more or better: (1) knowledge exchange with, (2) know-
ledge products for, and (3) knowledge use by stakeholders?
In general, research leaders had neutral views (see Fig. 4
and Table A3). They perceived only minor improvements
in the exchange of scientific knowledge with their stake-
holders. Again, pre-clinical group leaders predominantly
had a more neutral view about the improved knowledge
dissemination with stakeholders, while para-clinical and
clinical group leaders were somewhat more positive.10
The last question is whether research leaders’ views on
the importance of societal research goals are related to
interactions with and knowledge dissemination to various
societal stakeholders. Indeed, the more positive the
opinions are about societal orientation of research, the
higher the level of perceived interactions with various
stakeholders; and the more perceived knowledge
exchange with, the more knowledge products for, and
the more knowledge use by stakeholders (see Table 2).
The correlations found are moderate (>0.25) to strong
(>0.50). Of course, these results are based on
self-reporting, and those who think societal impact is im-
portant, may be more inclined to report interaction with
stakeholders and knowledge dissemination. However, we
did not ask whether or not interaction with and dissemin-
ation to stakeholders took place, but how much the inter-
action was increased—and most principal investigators
answered the question (see the Ns in Table 2).
In summary, biomedical and health research leaders are,
on average, slightly positive about the increased societal
orientation of their research. Pre-clinical research leaders
have more neutral views, which are easy to understand, as
pre-clinical research is more ‘fundamental’ and therefore—
in general11—more distantly related to care, cure and
health policy issues. The more positive research leaders


















Figure 3. Opinions of research leaders on increased interactions with stakeholders.
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formulating the group’s research agenda, the more positive
they are about interactions with stakeholders, and the
more they think it results in knowledge dissemination to
stakeholders.
3.2 Societal output of biomedical and health
research groups
Whereas the previous section was about the societal orien-
tation of research leaders, we turn in this section to the
non-scholarly output of research. The biomedical and
health groups produced different types of societal
research output. Products can be ‘tangible’, such as
reports, but we also included productive interactions
with stakeholders as output (Evaluating Research in
Context 2010). Table 3 lists the different products, the per-
centage of groups producing these types of output and the
amount produced (see also Table A2).
The most frequently mentioned products are: (1) pres-
entations about research results to non-scientific audi-
ences, such as professionals, patients and the general
public; (2) presentations in public media, such as TV,
radio and newspaper, in order to communicate research
findings to the general public; and (3) educational activities
for professionals in the private sector, policy sector or in
















Figure 4. Opinions of research leaders on increased knowledge dissemination to stakeholders.
Table 2. Societal research goals by interaction with stakeholders and knowledge dissemination (Spearman’s rho)
















Research in my group takes societal
needs into account
0.553* 0.409* 0.390* 0.450* 0.267* 0.520* 0.557* 0.503*
N=182 182 182 183 182 178 177 178
Research in my group is adapted to
medical problems within society
0.366* 0.318* 0.287* 0.382* 0.275* 0.520* 0.455* 0.518*
182 182 182 183 182 178 177 178
Research in my group results in useful
practical innovations
0.474* 0.469* 0.342* 0.380* 0.338* 0.572* 0.562* 0.582*
182 182 182 183 182 178 177 178
*p< 0.001
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research groups, respectively. Research leaders could easily
indicate whether a specific type of societal output has been
produced, but found it difficult to estimate how much. On
average, only half of the research leaders reported this.
In general, we did find a moderate positive relationship
between the societal orientation of research leaders and
societal research output.12 In other words, research
leaders who have more positive views about societal
research goals, improved interaction with stakeholders
and growing knowledge dissemination to stakeholders
are more active in realising societal output.
Differences exist among medical disciplines concerning
societal research output. In general, para-clinical groups
are most active and productive in realising societal
output, while pre-clinical groups are least active and pro-
ductive in realising societal output (Table 4).13 In particu-
lar, para-clinical groups are significantly more active in
realising policy reports and in participating in committees
for funding societal-oriented research than pre-clinical and
clinical groups. Pre-clinical groups are significantly less
active in participating in committees for developing
guidelines or policy recommendations and in generating
professional publications. Moreover, para-clinical groups
were also more productive than their pre-clinical and
clinical colleagues. They were significantly more product-
ive in giving presentations to non-scientific audiences,
contributing to the public media, writing policy reports
and participating in funding committees that stimulate
societal biomedical and health research. In contrast,
pre-clinical groups were less productive in comparison
with their para-clinical and clinical colleagues.
Specifically, they were significantly less productive in
giving presentations and educating or giving courses to
policy makers or professionals, and they were less often
members of committees that develop guidelines or policy
recommendations.
In conclusion, biomedical and health research groups
produce a variety of societal research output. Para-
clinical researchers are the most active and productive in
this respect, while clinical researchers are more active and
productive than the pre-clinical researchers. Furthermore,
research leaders who are more positive about the increased
emphasis on societal impact are more active in realising
societal output. Finally, it seems that research leaders are
not familiar with reporting the amount of societal output.
3.3 Health care relevance of biomedical research:
the virology case
Section 3.2 addressed the direct way of creating societal
impact by producing non-scholarly output. In contrast,
this section focuses on the indirect way of creating
societal impact. In particular, we investigate whether or
not fundamental (pre-clinical) biomedical research is
oriented at societal health care issues, and whether or
not that has changed over time. As research programmes
have to generate expectations of relevance in order to
acquire funding, the research programmes do not seem
appropriate places to study the societal orientation of
research. A better way of finding indicators for societal
orientation may be found in research output. Two indica-
tors come to mind. First, are fundamental biomedical





1 Presentations to non-scientific public Percentage of groups 84% 63%
Mean of output 8.9
2 Contributions to public media Percentage of groups 76% 57%
Mean of output 7.0
3 Education/courses for professionals Percentage of groups 69% 47%
Mean of output 6.9
4 Membership of committees developing guidelines/policy recommendations Percentage of groups 67% 48%
Mean of output 3.0
5 Contributions to conferences directed to stakeholders Percentage of groups 66% 48%
Mean of output 7.0
6 Professional publications Percentage of groups 65% 48%
Mean of output 17.5
7 Clinical guidelines Percentage of groups 54% 41%
Mean of output 2.7
8 Policy reports Percentage of groups 38% 27%
Mean of output 2.8
9 Editorship of societal-oriented biomedical and health journals Percentage of groups 38% 22%
Mean of output 2.5
10 Membership of committees funding societal-oriented biomedical/health research Percentage of groups 34% 26%
Mean of output 2.5
yN=184, four missing values
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journals cited by the more applied ones that focus on
clinical problems? In other words, is basic biomedical
research a knowledge input for clinical research that is
more directly oriented towards medical practice?
Secondly, are fundamental biomedical research papers ad-
dressing important health-related issues?
We use virology, one of the pre-clinical research fields,
as an example. The Journal of Virology is the most cited
journal in the field. Analysing the citation environment of
this journal, we found the citation network of virology
research as presented in Table 5. The columns give the
distribution of references from the field indicated in the
column heading over the research fields represented in
the rows. In the core of the network is the virology
cluster, consisting of some 20 virology journals. As
shown in Table 5, virology draws heavily on molecular
cell biology: 23.7% of all citations from the virology
cluster refer to this research field. Virology journals also
often cite immunology journals (8.3%) and the main
multidisciplinary journals Science and Nature (7.9%).
Smaller knowledge sources for virology are AIDS
research and research on infectious diseases, vaccine
research and immunology.
Taking the perspective from more application-oriented
research fields, such as AIDS research and vaccine research
(the last two columns), we can identify whether or not
virology is a knowledge source for these fields. Both
fields cite virology journals heavily, indicating the rele-
vance of virology for these more applied fields. These
citation patterns suggest that the knowledge exchange
between pre-clinical fields (virology, but also in this case
molecular biology, and immunology) and the clinical fields
(AIDS, infectious and tropical diseases, vaccine research)
is fairly intensive. We compared this pattern with previous
years, and the citation network is stable.
Another indicator of societal orientation is based on the
titles of papers in virology journals. Do the titles point at
diseases and therapies, or at fundamental cellular and bio-
logical processes, including laboratory techniques? Table 6
lists the most frequently occurring title words and author
keywords. Many of these refer to either clinically import-
ant viruses that cause human infections, or therapies and
drugs (italics in Table 6). This pattern has also been stable
over the years.
If we generalise the findings on virology, we may
conclude that pre-clinical (‘fundamental’) fields are
strongly oriented to clinical issues. Moreover, citation re-
lations show that they inform the clinical fields to a con-
siderable extent. In other words, the increased attention to
the societal benefits of research does not appear to be
related to a lack of such relevance. Rather, it may more
strongly reflect the quest for a clearer engagement with
societal relevance through the direct communication with
a variety of societal stakeholders.
Table 4. Societal output of research groups by discipline (2004–6)y



















Presentations % groups 92.0% 68% 77.2% 63% 87.5% 61%
Mean units per FTE 1.67* 0.30* 0.44
Public media % groups 84.0% 64% 65.8% 52% 82.5% 59%
Mean units per FTE 0.72* 0.34 0.39
Education/courses % groups 84.0% 56% 59.5% 43% 72.5% 48%
Mean units per FTE 0.74 0.26* 0.55
Cie’s developing guidelines/policies % groups 80.0% 60% 51.9%* 39% 77.5% 54%
Mean units per FTE 0.29 0.13* 0.20
Conferences/symposia % groups 80.0% 60% 50.6% 41% 77.5% 51%
Mean units per FTE 0.57 0.28* 0.45
Professional publications % groups 92.0% 60% 46.8%* 39% 75.0% 53%
Mean units per FTE 1.08 0.79 1.32
Clinical guidelines % groups 52.0% 40% 39.2% 30% 70.0% 51%
Mean units per FTE 0.20 0.13 0.22
Policy reports % groups 76.0%* 60% 25.3% 19% 38.8% 24%
Mean units per FTE 0.44* 0.11 0.10
Editorship societal-oriented journals % groups 48.0% 36% 29.1% 20% 43.8% 29%
Mean units per FTE 0.22 0.18 0.15
Cie’s funding societal-oriented research % groups 64.0%* 48% 24.1% 19% 33.8% 29%
Mean units per FTE 0.26* 0.12 0.14
yn=25 para-clinical groups (one missing value); n=79 pre-clinical groups (one missing value); n=80 clinical groups (two missing values)
*Significantly different at p< 0.05
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3.4 Societal and scientific productivity
It is often argued that societal orientation negatively influ-
ences the scholarly quality of research (Royal Society
2006). However, studies measuring societal output and
scholarly performance show different results. A study of
Norwegian university professors (Gulbrandsen and Smeby
2005) measured the entrepreneurial output of researchers
in terms of whether or not R&D activities had resulted in
commercial results such as patents, products, establish-
ment of firms, and consulting contracts.14 This study
found that entrepreneurial output is not significantly
related to academic output. A study of societal quality in
a UMC in the Netherlands (Mostert et al. 2010) showed no
relationship between societal and scientific quality. Finally,
a French study (Jensen et al. 2008) examined the relation-
ship between popularisation activities (e.g. public or school
conferences, interviews in newspapers, collaboration with
associations) and academic activities (number of papers
and citations). This study found that the various discip-
lines differ in this respect. No relationship was found
between engineering and chemistry, but a modest
positive relation was found between the life sciences. Van
Looy et al. (2011) recently showed that at university level
scientific productivity is positively associated with entre-
preneurial performance, measured as patents, spin-offs
and contract research. A similar relation also holds at
the level of the individual academic researcher, as shown









Virology 55.2% 3.4% 4.5% 2.1% 19.7% 25.7%
Molecular cell biology 23.7% 71.7% 26.1% 36.3% 10.0% 10.0%
Immunology 8.3% 6.6% 55.7% 5.0% 16.8% 19.8%
Multidisciplinary sciencey 7.8% 17.9% 12.1% 56.2% 8.1% 7.1%
AIDS and infectious diseases 3.8% 0.3% 1.2% 0.4% 42.5% 9.7%
Vaccine research 1.2% 0.1% 0.5% 0.1% 2.9% 27.7%
yThis set consists of journals such as Science, Nature and PNAS
Table 6. Title words and author keywords of papers in virology journals
Word freq Word freq Author keyword Freq Author keyword Freq
Virus 2447 Cytomegalovirus 125 HIV1 86 HBV 25
Human 920 Identification 122 HIV 85 West Nile virus 25
Protein 767 Genetic 118 Real time pcr 74 Replication 24
Infection 726 Binding 116 Rotavirus 48 Molecular epidemiology 24
Cells 433 Genome 115 Hepatitis C virus 48 Elisa 24
Hepatitis 401 T-cell 112 Pcr 48 Epstein-Barr virus 24
Immunodeficiency 384 Acute 108 Rtpcr 45 Flavivirus 24
HIV 375 Envelope 106 Genotype 45 Genotyping 23
Viral 350 Entry 105 Phylogenetic analysis 44 Baculovirus 23
RNA 270 Assay 104 Norovirus 44 SIV 22
Replication 253 Sequence 103 Interferon 38 Detection 21
Influenza 235 Murine 102 Cytomegalovirus 36 HPV 21
Expression 219 Activity 101 Adenovirus 35 Influenzavirus 21
Cell 212 Vaccine 99 Apoptosis 33 Enterovirus 21
Gene 188 Antibody 99 Vaccine 31 Resistance 20
Characterisation 186 Activation 99 Gastroenteritis 30 Children 20
DNA 170 Receptor 98 Epidemiology 29 Ribavirin 19
Disease 169 Papillomavirus 97 Influenza 29 Influenza A virus 19
Herpes 156 Region 96 Hepatitis B virus 28 Neutralisation 19
Respiratory 147 Responses 92 Real time rtpcr 28 SARS-CoV 18
Simplex 142 Real-time 91 Genotypes 28 Human cytomegalovirus 18
Patients 131 Cellular 90 HCV 27 Coinfection 17
Mice 129 Domain 90 Diagnosis 27 Innate immunity 17
Molecular 128 Herpesvirus 90 Pathogenesis 25 Gene therapy 17
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by van Looy et al. (2006): the more prolific scientists
emerge as those who are more likely to patent.
We answer this question for Dutch biomedical and
health research. Research quality is high in this domain,
when measured in publication volume and citation impact
(NOWT 2010). In the period 2004–6, the biomedical and
health groups in our sample published an average of 1.9
papers per FTE (29 papers per group) in journals indexed
in the Web of Science. As Table 7 indicates, no significant
correlations exist between the scientific and societal prod-
uctivity of the research groups. This holds for all types of
societal output considered in this study. However, there is
evidence suggesting a moderate negative correlation
between societal output and scientific impact (Table 7).
More specifically, scientific impact correlates negatively
with most types of societal output—apart from profession-
al publications, clinical guidelines and grant allocation
committee membership. These types of societal output
seem more closely related to scholarly output (professional
publications and medical guidelines) than the others (in-
formation for the general public, and for societal stake-
holders, education and editorial work).
Summarising, societal relevant output does not auto-
matically follow from highly productive research, but
neither does it hinder productive research. Several types
of societal output do not seem to hinder high-impact
research, but others do. This is probably because it is un-
certain whether investing time in these activities will result
in scholarly spin-offs. This leads to the next, and last
question of this paper: under which conditions can
research simultaneously be of high scholarly and societal
quality?
3.5 Management, organisation and societal output
of research groups
The fifth question we address is to what degree the man-
agement and organisational characteristics of biomedical
and health research groups might influence societal output.
In other words, we investigate whether or not managerial
and organisational conditions such as: the influence of
funding profiles, leadership experience, group size, work
environment and translational research, are related to
societal orientation and the output of research groups.
3.5.1 Funding. Biomedical and health research increas-
ingly depends on external funding. Consequently,
research councils and other funding organisations place
an emphasis on societal relevance, which may influence
the research strategies and, as a consequence, the level of
the societal output of groups. How do the various modes
of research funding influence the production of societal
output? In order to answer that question we distinguish
between four different funding arrangements, each with
different conditions: (1) (basic) institutional funding; (2)
funding by research councils; (3) commissioned research
funded by industry or government; and (4) funding by
charities. Research groups differ in their strategies,
possibilities and capabilities for attracting funding from
these sources, which results in different funding profiles.
Do these profiles relate to the quantity of societal output of
research groups? Table 8 shows the correlations between
the percentage of funding coming from the different
sources and the quantity of societal output.
Institutional funding correlates positively with the
quantity of societal output. Groups with a relatively high
percentage of institutional funding produced, for instance,
more clinical guidelines and participated more intensively
in societal committees and editorial boards.
We did not find any positive relationship between the
proportion of funds coming from (pharmaceutical)
industries, companies or government ministries and the
societal output of biomedical and health research groups.
In fact, biomedical and health groups that receive a high
percentage of funding from these sources mostly conduct
Table 7. Societal productivity per category by scientific productivity and impacty
Spearman’s rho N
Scientific productivity Scientific Impact
Presentations to non-scientific public 0.007 0.190** 114
Contributions to public media 0.071 0.235** 101
Education/courses for professionals 0.102 0.217** 84
Membership of committees developing guidelines/policies 0.000 0.085 88
Contributions to conferences directed to stakeholders 0.046 0.177* 86
Professional publications 0.012 0.051 86
Clinical guidelines 0.065 0.211* 74
Policy reports 0.052 0.239* 48
Editorship of societal-oriented journals 0.241 0.357** 47
Membership of committees funding societal-oriented research 0.006 0.160 40
yMentioned type of societal output (units per FTE) is by scientific output (papers per FTE) and impact (citations per FTE)
*p< 0.10, **p< 0.05
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contract research with a societal or economic goal for these
societal stakeholders.15 In other words, we assume that the
societal output is anchored in the research commissioned.
Groups that obtained more funding from charities
scored significantly lower on several types of societal
output products than others. This observation can be ex-
plained by the funding conditions of charities. Although
charities focus on specific diseases (e.g. cancer or heart
diseases) in their project selection process, they mainly
concentrate on the scientific quality of the proposal.
Dutch charities do not explicitly take societal relevance
and societal output into account when selecting research
proposals.16 Most probably, research funded by charities is
intrinsically of social relevance since it targets a disease:
societal impact is expected to emerge from the contribution
to new knowledge about a specific disease.
Finally, the proportion of funding from all research
councils together17 is not related to societal output.
However, when we only consider the number of grant
applications to the ZonMw council a moderate positive
correlation exists between the number of grants obtained
and societal productivity. The more frequently research
groups apply for funding and receive grants from
ZonMw, the more societal output is produced.
Interestingly, this council strongly emphasises the need
for socially relevant research and uses societal orientation
in their proposal assessment criteria. Our analysis suggests
that this seems to be effective (Table 9). The opposite is the
case for the other research councils18 in our study: they do
not assess the societal quality of proposals in an explicit
way, with the expected result. In conclusion, assessment
procedures of research funding agencies are potentially
powerful incentives and have serious implications for the
behaviour of biomedical and health scientists.
3.5.2 Leadership experience. Research management
and leadership activities such as internal communication









Presentations to non-scientific public 0.287*** 109
Contributions to public media 0.420*** 99
Education/courses for professionals 0.267** 82
Membership of committees developing guidelines/policy recommendations 0.183* 0.193* 84
Contributions to conferences directed to stakeholders 0.379*** 86
Professional publications
Clinical guidelines 0.288** 69
Policy reports 0.280* 0.307** 46
Editorship of societal-oriented journals 0.355** 46
Membership of committees funding societal-oriented research 0.453*** 46
yPercentage of funding from mentioned source
*p< 0.10, **p< 0.05, ***p< 0.01
Table 9. Societal productivity by ZonMW-activityy
Spearman’s rho N
Presentations to non-scientific public 0.352*** 114
Contributions to public media 0.240** 101
Education/courses for professionals 0.225* 84
Membership of committees developing guidelines/policy recommendations 0.205* 88
Contributions to conferences directed to stakeholders 0.272** 84
Professional publications
Clinical guidelines
Policy reports 0.373*** 48
Editorship of societal-oriented journals
Membership of committees funding societal-oriented research 0.428*** 40
yZonMw activity is number of proposal submissions and received grants normalised for group size
*p< 0.10, **p< 0.05, ***p< 0.01
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and rewarding structure are positively correlated with
scholarly performance (Van der Weijden 2007; Van der
Weijden et al. 2008). However, the way in which research
leaders manage their groups did not seem to relate to the
societal output of research groups. Nevertheless, experi-
ence in leadership and management is related to the
societal output of research leaders. Groups that have
more experienced research leaders produce less societal
research output, such as contributions to public media,
presentations for a non-scientific public, policy reports,
professional publications, contributions to non-scholarly
conferences, education of professionals and memberships
of committees developing clinical guidelines and policy
recommendations (see Table 10). This suggests that the
younger generation of principal investigators is more
aware of the increased societal demand for relevance.
3.5.3 Group size. Group size also correlates negatively
with societal productivity (see Table 10). For example,
smaller groups developed more clinical guidelines,
produced more policy reports and gave more presentations
to non-scientific audiences per group member.
Furthermore, research leaders of smaller groups were
more often editors of professional journals as well as
members of committees for developing guidelines, policy
recommendations and funding societal-oriented research.
Why this is the case needs further exploration. Are
research leaders who focus on societal output less inter-
ested in acquiring research money for building up a large
group? Or are research leaders inclined to reduce their
societal activities, when the research group grows in size
and an increasing amount of time is needed to manage it?
3.5.4 Work environment. University-based groups were
more active in realising various types of societal output
than non-university groups. In comparison with
non-university groups, a significantly higher percentage
of the university-based groups gave presentations to a
non-scientific public, contributed to the public media,
participated in committees for developing guidelines or
policy recommendations, contributed to stakeholder con-
ferences, realised professional publications and developed
clinical guidelines.19 Principal investigators working in
universities also had more positive opinions about: (1)
societal goals (i.e. adaptation to medical problems in
society and useful practical innovations); (2) interactions
with societal stakeholders (i.e. patient organisations and
policy makers); and (3) knowledge dissemination (i.e.
knowledge exchange, products and use), than their col-
leagues at public research institutes.20
3.5.5 Translational research. Finally, one of the mani-
festations of the increased focus on societal impact is the
emergence of translational medical science: research that
aims to translate fundamental knowledge into applicable
treatments. That is, research that moves from bench to
bedside. Increasingly, biomedical research is organised in
this way. Using pre-clinical research groups (bench) that
spend time on patient care (bedside) as indicators of
Table 10. Societal productivity by leadership experience and group sizey
Leadership experience Group size
Presentations to non-scientific public Spearman’s rho 0.203** 0.408***
N 113 116
Contributions to public media Spearman’s rho 0.252** 0.203**
N 101 104
Education/courses for professionals Spearman’s rho 0.394*** 0.307***
N 84 86
Membership of committees developing guidelines/policies Spearman’s rho 0.421*** 0.396***
N 86 89
Contributions to conferences directed to stakeholders Spearman’s rho 0.217** 0.375***
N 87 88
Professional publications Spearman’s rho 0.273**
N 85
Clinical guidelines Spearman’s rho 0.522***
N 75
Policy reports Spearman’s rho 0.379*** 0.527***
N 48 49
Editorship of societal-oriented journals Spearman’s rho 0.482***
N 48
Membership of committees funding societal-oriented research Spearman’s rho 0.357**
N 41
yThe mentioned type of societal output (units per FTE) by leadership experience (in years) and group size (FTE)
* p< 0.10, ** p< 0.05, *** p< 0.01
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translational medical science, we found that pre-clinical
‘translational research’ groups21 are more active in
generating societal output than those that do not spend
time on patient care.
This exploratory study provides answers to our five
research questions, as it gives a first impression of the
views and activities of Dutch biomedical researchers with
respect to societal orientation. Two limitations should be
mentioned here: first, the results were collected in a
one-shot study, and so our results cannot be compared
over time; and secondly, the sample size creates restrictions
for a more in-depth analysis.
4. Conclusions and discussion
We have demonstrated that, on average, principal investi-
gators have a slightly positive attitude towards the
increased emphasis that policy makers and research
managers put on the societal impact of research. Their
societal orientation is expressed in societal goals, commu-
nication with stakeholders and the dissemination of know-
ledge to stakeholders. A positive view towards societal
orientation leads to more activity in order to realise
societal output. Biomedical and health research groups
produce a broad range of societal outputs. Principal inves-
tigators are not used to reporting the amount of societal
output, which is not surprising, since the measurement of
societal output is not implemented in research evaluation
system in the same way scientific output is.
The three disciplines that we distinguished between
differ in their societal orientation and societal output.
Para-clinical groups are most active and productive in
generating societal output, followed by clinical groups.
Pre-clinical groups are least active and productive and
they also have somewhat more neutral views towards
societal orientation. Yet, pre-clinical research—as shown
for the virology case—is oriented toward, and relevant for,
clinical studies, and consequently, for clinical practice. In
other words, pre-clinical groups seem to disseminate new
knowledge to stakeholders via scholarly output. It seems
that pre-clinical groups express their societal orientation
indirectly at the research field level instead of directly via
measurable societal output on a group level. Only when
pre-clinical groups spend time on patient care, i.e. do
translational research, are they more active in generating
societal output. Apparently, translational research stimu-
lates a broader societal orientation.
In our case we found that scientific and societal prod-
uctivity are independent. Groups exist that have both high
scientific and high societal productivity, groups that have
both low scientific and low societal productivity, and
groups that have high (or low) scientific productivity and
low (or high) societal productivity. An orientation towards
the wider socio-economic benefits of research is thus cer-
tainly not a residual task for researchers ‘who are not good
enough for an academic career’ (Royal Society 2006).
However, some types of societal output correlate moder-
ately negatively with scholarly impact, while others do not.
This suggests that specific efforts are required to stimulate
societal research output, and that societal impact is not
simply the consequence of policies which stimulate high
scientific quality.
What could these specific policies look like? Our study
found several managerial and organisational characteris-
tics that relate to societal output and this leads to some
policy implications. The relationship between the type of
funding and societal output is mixed, which might be a
result of the assessment procedures used by research
funding agencies. Institutional funding correlates positive-
ly with societal productivity. In contrast, charity funding
correlates negatively with societal productivity. This could
be a result of their project selection criteria, since charities
mainly focus on the scientific quality of proposals. Perhaps
charities perceive the creation of new knowledge about a
specific disease as socially relevant, and they might dissem-
inate this new knowledge to a wider society themselves
rather than leave this as a task for the researchers.
No relationship was found with funding from industry
and ministries. Actually, it is conceivable that the
research commissioned by these stakeholders already has
a societal or economic goal. Therefore, funding received
from industry and ministries can be considered to be a type
of societal output. Finally, funding from research
councils—received in competitions—does not correlate
with societal output. Not surprisingly, because they do
not assess the societal quality of proposals. However,
this seems different for the ZonMw which explicitly stimu-
lates societal relevance in its selection procedures. Here we
found that research groups that apply more often for
grants and receive more grants from this council, are
also generating more societal output. In conclusion,
making societal relevance a condition for research
funding would create a vigorous incentive, as this seems
to influence the behaviour of research leaders.
Principal investigators with less leadership experience
are more productive in realising societal output. This
could be a generational effect. The increasing need to dem-
onstrate socio-economic benefits from investments in
research affects the strategies of research groups. The
younger generation of research leaders may adapt to this
with more ease than the older generation (Verbree et al. in
press). However, we are aware that a longitudinal (panel)
study is needed to verify statements about generational
differences and the effects of experience. We plan to do
this in the future. We also found a negative relationship
between group size and societal output, suggesting that
there is a trade-off between societal orientation and
trying to create a large research group. This merits
further investigation. Finally, the effect of a work environ-
ment on societal orientation calls for further research. Do
university-based research groups have a stronger societal
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orientation than other research groups, because
universities stimulate this?
Overall, our study shows a relatively strong orientation
to societal relevance within the Dutch biomedical and
health research fields, and this reflects the changing
contract between science and society. However, we do
realise that the connections between science and practice
might be easier to make in the medical sciences than in
other academic fields, such as physics or other natural
sciences. Therefore it would be interesting to also study
societal orientation in other academic scientific domains,
which would allow us to compare results between discip-
lines. As Dutch biomedical and health research is interna-
tionally at the top of the discipline (NOWT 2010), we
consider these results to be more generally relevant.
Whereas in the past, society funded research with the ex-
pectation that societal pay-off would come at a certain
point, nowadays society increasingly expects the inclusion
of social benefits in research programming and in research
from the outset. The younger generation of researchers
takes up this challenge more explicitly than the older gen-
eration. This indicates a change in the science system in
this respect: the new generation of principal investigators
adapts its attitude in response to the changing science–
society relationship (Verbree et al. in press). This adapta-
tion of research leaders to the changing science–society
relationship can potentially be reinforced by implementing
incentives in funding allocation processes.
However, the incentives for focusing on societal impact
are still weak within the science system, as research evalu-
ation systems have only recently started to include societal
impact as one of their criteria. The process of knowledge
transfer to society may be improved considerably by sup-
porting the societal orientation of research leaders in a
more explicit manner (De Jong et al. 2011). The current
incentive structure in the science system, including research
careers, still seems largely based on scientific performance
in a narrow sense. It has been pointed out that ties to
society and political bodies do not lead to pay-offs that
can be mapped by the conventional indicators of successful
scientific performance, including contract funding
(Atkinson-Grosjean and Douglas 2010; Krücken et al.
2009; Göransson et al. 2009; Hessels 2010). Universities,
for example, like to exhibit their societal engagement, but,
in practice, these activities remain largely unrewarded.
Financial rewards may be an instrument for stimulating
the broader impact of university research (Hessels and
van Lente 2010). A study by a German university
(Krücken et al. 2009) showed that societal output activities
were all dependent on the personal motivation, voluntary
commitment and informal, pre-existing personal ties of
academic scientists. In addition, Jensen et al. (2008)
showed that dissemination activities of French scientists
have almost no (positive or negative) impact on their sci-
entific careers. We expect a reduction in tensions between
organisational goals and individual goals once societal
activities are no longer valued as ‘leisure time activities’,
and instead play a role in evaluating performance. This
may help to solve the problem that junior scientists are
rarely active in generating societal output (Göransson
et al. 2009). Scientists should engage in a two-way
dialogue with stakeholders at an early stage in their
careers (Winston 2009). This idea is supported in the
medical field.22 Incentives aiming to intensify collabor-
ations between academia and societal practitioners are a
main factor for accomplishing socially relevant knowledge
(De Jong et al. 2011; Knights and Scarbrough 2010). In
conclusion, universities and research institutes now have a
duty to evaluate both scientific and socially relevant output
(Jensen et al. 2008). As a consequence, scientists should
also be rewarded when they are active in producing
socially relevant output.
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Notes
1. In this study research group leaders are defined as
principal investigators. The research group is the
smallest unit at the micro-level of knowledge
production.
2. Translational research is a contested term. Some use it
for research that goes from the lab to clinical applica-
tion, some for research that goes from clinical appli-
cation to large-scale use. We use it for the whole
trajectory.
3. A study of the Netherlands Institute for Health
Promotion (NIGZ) and the Netherlands
Organization for Applied Scientific Research (TNO)
showed that Dutch policy makers view scientific infor-
mation as not directly applicable and relevant to
making contributions in the policy-making process
(Keijsers et al. 2005).
4. The Netherlands Organisation for Health Research
and Development.
5. Information on the ERiC project is available at
<http://www.eric-project.nl>, accessed 20 March
2012. The related EU-funded SIAMPI project has
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similar aims. Information about it is available at
<http://www.siampi.eu>, accessed 20 March 2012.
6. This process can go both ways. Observations made in
the clinic during the treatment of patients may feed
back to inform basic research questions which seek
to understand the effects seen in the clinical therapies.
In this paper we primarily focus on the flow from basic
research towards application.
7. Scholarly performance is defined here as the number
of publications over a three-year period (2004–6).
Thomson Reuters (formerly ISI) Web of Knowledge
and PubMed (US National Library of Medicine’s
search service) were used as data sources.
8. Mann–Whitney tests with a Bonferroni correction
show that leaders of pre-clinical groups differ signifi-
cantly (with a level of significance at 0.10) from para-
clinical leaders in their attitude towards taking societal
needs into account, adapting to medical problems
within society, contributing to useful practical innov-
ations from clinical leaders, and in their attitude
towards taking societal needs into account.
9. Mann–Whitney tests with a Bonferroni correction
show that leaders of pre-clinical groups differ signifi-
cantly (with a level of significance at 0.10) in their
attitude towards interactions with stakeholders from
para-clinical leaders (viz. professionals in prevention
and care and policy makers) and clinical leaders (viz.
policy makers and patient organisations).
10. Mann–Whitney tests with a Bonferroni correction
show that leaders of pre-clinical groups differ signifi-
cantly (with a level of significance at 0.10) in their
attitude towards knowledge dissemination from
leaders of para-clinical and clinical leaders.
11. This is not always the case. Ethical issues are often
involved in pre-clinical research.
12. This was calculated with point biserial correlations
between activity in societal output (yes or no) and
views about societal research goals, interaction with
stakeholders, and knowledge dissemination to
stakeholders.
13. Pearson’s chi-square statistics show that para-clinical
research groups were significantly more active in the
mentioned societal output categories, and that
pre-clinical research groups were significantly less
active in the mentioned societal output categories,
with a level of significance at 0.05. Mann–Whitney
tests with a Bonferroni correction show that
para-clinical groups differ significantly in productivity
of the mentioned societal output products, and that
pre-clinical research groups differ significantly in
productivity of the mentioned societal output
products, with a level of significance at 0.05.
14. The questions were posed dichotomously (yes or no).
These types of societal output were not included in our
study.
15. In our study, the entrepreneurial activities and com-
mercial performance of research groups, such as the
identification and measurement of scientist-invented
patents were not taken into account. This will be
included in future research.
16. We verified their grant selection procedures on the
websites of three large charity funds in the
Netherlands, i.e., de Nederlandse Hartstichting
(<www.hartstichting.nl/research>, accessed 20
March 2012) (Dutch Heart Foundation); de Maag
Lever Darm Stichting (<http://www.mlds.nl/>,
accessed 20 March 2012) (Dutch Digestive
Foundation), and KWF Kankerbestrijding (<www.
kwfkankerbestrijding.nl>, accessed 20 March 2012)
(Dutch Cancer Society). We also verified the grant se-
lection procedures at the research councils in the
Netherlands.
17. Research councils in the Netherlands: NWO is the
Dutch Research Council; ZonMw is the Dutch
Research Council for Medical Science; KNAW is the
Royal Netherlands Academy of Arts and Sciences.
18. The other research councils refer to NWO and
KNAW (see also Note 15).
19. Pearson’s chi-square statistics show that
university-based groups were significantly more
active in generating various societal output than
non-university groups. No significant differences
were found for policy reports, education or courses
for professionals, editorship of societal-oriented bio-
medical and health journals, and committee member-
ship for funding societal-oriented biomedical and
health research.
20. Mann–Whitney tests show significant differences
between university-based groups and non-university
groups in societal orientation, with a level of signifi-
cance at 0.05.
21. Pearson’s chi-square statistics show that a higher per-
centage of pre-clinical research groups that spent time
on patient care generated societal output compared to
pre-clinical research groups that did not spend time on
patient care. Specifically, there was a significant asso-
ciation between patient care and realising presenta-
tions to non-scientific public (89.2% vs. 66.7%,
p< 0.05), contributions to media (81.1% vs. 52.4%,
p< 0.01), education/courses for professionals (70.3%
vs. 50.0%, p< 0.10), guidelines/policy recommenda-
tions (81.1% vs. 26.2%, p< 0.001), contributions to
conferences for stakeholders (62.2% vs. 40.5%,
p< 0.10), professional publications (59.5% vs.
35.7%, p< 0.05), clinical guidelines (75.7% vs. 7.1%,
p< 0.001) and policy reports (43.2% vs. 9.5%,
p< 0.01).
22. We presented our research to 72 biomedical and health
research leaders in the Netherlands who are working
in three different UMCs. 71% shared the opinion that
scientists should be stimulated to think about the
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possible societal impact of their research projects at a
very early phase in their academic careers.
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Appendix
Table A1. Descriptive statistics of opinions of research leaders on societal research goals
N Median Bottom
quartile
Top quartile Mean SD
Research in my group takes societal needs into account Para-clinical 25 4.00 4.00 4.00 3.80 0.957
Pre-clinical 78 4.00 3.00 4.00 3.42 0.933
Clinical 80 4.00 3.00 4.00 3.76 0.945
Research in my group is adapted to medical problems within society Para-clinical 25 4.00 3.00 4.00 3.64 1.036
Pre-clinical 78 4.00 3.00 4.00 3.42 0.974
Clinical 80 4.00 3.00 5.00 3.83 1.063
Research in my group results in useful practical innovations Para-clinical 25 4.00 3.00 4.50 3.64 1.114
Pre-clinical 78 4.00 3.00 4.00 3.40 1.024
Clinical 80 4.00 3.00 4.00 3.79 0.910
Five-point scale with 1 is ‘totally disagree’, 3 is ‘not disagree, not agree’, 5 is ’totally agree’
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Table A2. Descriptive statistics of opinions of research leaders of increased interactions with stakeholders
N Median Bottom quartile Top quartile Mean SD
Professionals in prevention and care Para-clinical 25 4.00 3.00 4.50 3.76 1.012
Pre-clinical 77 3.00 3.00 4.00 3.36 0.842
Clinical 80 4.00 3.00 4.00 3.58 0.897
Policy makers Para-clinical 25 4.00 3.00 4.00 3.64 1.036
Pre-clinical 77 3.00 3.00 4.00 3.12 0.827
Clinical 80 4.00 3.00 4.00 3.53 0.900
General public Para-clinical 24 4.00 2.25 4.00 3.42 1.018
Pre-clinical 78 3.00 3.00 4.00 3.19 0.913
Clinical 80 4.00 3.00 4.00 3.45 0.013
Patient organisations Para-clinical 25 3.00 3.00 4.00 3.44 1.121
Pre-clinical 78 3.00 2.75 4.00 3.12 0.882
Clinical 80 4.00 3.00 4.00 3.43 0.911
Industry Para-clinical 25 3.00 2.00 4.00 2.92 1.152
Pre-clinical 77 3.00 2.00 4.00 3.10 0.882
Clinical 80 3.00 2.25 4.00 3.20 1.060
Five-point scale with 1 is ‘totally disagree’, 3 is ‘not disagree, not agree’, 5 is ’totally agree’
Table A3. Descriptive statistics of opinions of research leaders of increased knowledge dissemination to stakeholders
n Median Bottom quartile Top quartile Mean SD
Knowledge exchange Para-clinical 25 4.00 3.00 4.00 3.76 0.879
Pre-clinical 75 3.00 3.00 4.00 3.20 0.900
Clinical 78 4.00 3.00 4.00 3.54 0.863
Knowledge products Para-clinical 25 4.00 3.00 4.00 3.56 1.003
Pre-clinical 74 3.00 2.00 4.00 3.00 0.979
Clinical 78 3.00 3.00 4.00 3.32 0.987
Knowledge use Para-clinical 25 3.00 3.00 4.00 3.36 0.757
Pre-clinical 75 3.00 2.00 4.00 2.99 0.951
Clinical 78 3.00 3.00 4.00 3.37 0.839
Note: five-point scale with 1 is ‘totally disagree’, 3 is ‘not disagree, not agree’, 5 is ’totally agree’
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